
Actuated Medical Inc (AKA: PRII~Piezo Resonance Innovations Inc) Profile last edited on: 10/7/2022
CAGE: 4NZ54
UEI: VG84D4KN5LR5
Business Identifier: Next-generation, FDA-compliant medical devices Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
310 Rolling Ridge Drive
Bellefonte, PA 16823
Bellefonte, PA 16823
(814) 355-0003 |
info@actuatedmedical.com |
www.actuatedmedical.com |
Location: Single
Congr. District: 15
County: Centre
Congr. District: 15
County: Centre
Public Profile
Long time and very effectively SBIR-involved, Actuated Medical is a medical device development firm integrating electronically controlled motion technologies designed to improve patient outcomes and to reduce healthcare costs. Ever he good neighbor, they give back to the community by providing frequent STEM opportunities to middle school, high school and college students. They also provide summer engineering internships to high school and college students so that these young people can learn about medical device development, FDA regulations and clinical end-user discovery.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
20-24Revenue Range
2M-2.5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
50-74Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2024 | 2 | NIH | $5,755,810 | |
Project Title: Active Disposable Cap for Endoscope Tip Stabilization and Complete Visualization and Dissection of Serrated Sessile Polyps | ||||
2024 | 2 | NIH | $1,386,893 | |
Project Title: Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment | ||||
2024 | 1 | NIH | $456,205 | |
Project Title: Development of an Oscillated Insertion tool to Eliminate Surgically Induced Neurodegeneration for Optical Neuroimaging of Cognitive Aging and Dementia | ||||
2023 | 2 | NIH | $2,794,637 | |
Project Title: Development of an Acoustic Implant Protection System to Improve Performance and Longevity of Neural Interfaces | ||||
2023 | 2 | NIH | $766,290 | |
Project Title: Development of a Miniaturized Wearable Ultrasonic Beam-forming Device for Localized Targeting of Brain Regions in Freely-moving Experimental Subjects |
Key People / Management
Roger B Bagwell -- Co-Founder Director Research and Development
Ian M Charney -- Manufacturing Leader
Ryan S Clement -- Pre-Clinical Studies Leader
Debora L Demers
Douglas R Dillon -- Director Quality Assurance & Regulatory Affairs
Paul L Frankenhouser -- Director of Innovation
Kyle W Gheres -- Neural Devices Leader
Christopher E Lahr -- Business Leader
Olga M Ocon-Grove -- Reimbursement Leader, Clinical Site Monitor, Senior Scientist
Kevin A Snook -- Medical Transducer Design Leader, Senior Bioacoustics Engineer
Bryan Wilson -- Strategic Planning Leader
Ian M Charney -- Manufacturing Leader
Ryan S Clement -- Pre-Clinical Studies Leader
Debora L Demers
Douglas R Dillon -- Director Quality Assurance & Regulatory Affairs
Paul L Frankenhouser -- Director of Innovation
Kyle W Gheres -- Neural Devices Leader
Christopher E Lahr -- Business Leader
Olga M Ocon-Grove -- Reimbursement Leader, Clinical Site Monitor, Senior Scientist
Kevin A Snook -- Medical Transducer Design Leader, Senior Bioacoustics Engineer
Bryan Wilson -- Strategic Planning Leader